Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-20-004906
Date:2020-02-14
Issuer: CONSTELLATION PHARMACEUTICALS INC (CNST)
Original Submission Date:

Reporting Person:

RAYTHATHA JIGAR
C/O CONSTELLATION PHARMACEUTICALS, INC.
215 FIRST STREET, SUITE 200 CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 36.06 2020-02-14 deemed execution date A 200,000 (a) 2030-02-13 common stock 200,000 $36.06 200,000 direct
Footnotes
IDfootnote
f1 this option was granted on february 14, 2020, and the shares underlying the option vest in equal quarterly installments through february 14, 2024, subject to continued service.
WhaleWisdom Logo

Elevate your investments